Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose-Response of Gonadal Steroids and Bone Turnover in Men

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Massachusetts General Hospital
Sponsor:
Collaborators:
National Institute on Aging (NIA)
Solvay Pharmaceuticals
AstraZeneca
AbbVie
Information provided by (Responsible Party):
Joel S. Finkelstein, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00114114
First received: June 13, 2005
Last updated: September 16, 2016
Last verified: September 2016